Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' MANN KG' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 150 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Butenas, S; Branda, RF; van't Veer, C; Cawthern, KM; Mann, KG
      Platelets and phospholipids in tissue factor-initiated thrombin generation

      THROMBOSIS AND HAEMOSTASIS
    2. Undas, A; Williams, EB; Butenas, S; Orfeo, T; Mann, KG
      Homocysteine inhibits inactivation of Factor Va by activated protein C

      JOURNAL OF BIOLOGICAL CHEMISTRY
    3. Kalafatis, M; Mann, KG
      The role of the membrane in the inactivation of factor Va by plasmin - Amino acid region 307-348 of factor V plays a critical role in factor Va cofactor function

      JOURNAL OF BIOLOGICAL CHEMISTRY
    4. Undas, A; Brummel, K; Musial, J; Mann, KG; Szczeklik, A
      PIA2 polymorphism of beta(3) integrins is associated with enhanced thrombin generation and impaired antithrombotic action of aspirin at the site of microvascular injury

      CIRCULATION
    5. Brummel, KE; Paradis, SG; Branda, RF; Mann, KG
      Oral anticoagulation thresholds

      CIRCULATION
    6. Undas, A; Brummel, KE; Musial, J; Mann, KG; Szczeklik, A
      Simvastatin depresses blood clotting by inhibiting activation of prothrombin, factor V, and factor XIII and by enhancing factor Va inactivation

      CIRCULATION
    7. Undas, A; Brummel, K; Musial, J; Mann, KG; Szczeklik, A
      Blood coagulation at the site of microvascular injury: effects of low-doseaspirin

      BLOOD
    8. Butenas, S; Cawthern, KM; van't Veer, C; DiLorenzo, ME; Lock, JB; Mann, KG
      Antiplatelet agents in tissue factor-induced blood coagulation

      BLOOD
    9. Butenas, S; van't Veer, C; Cawthern, K; Brummel, KE; Mann, KG
      Models of blood coagulation

      BLOOD COAGULATION & FIBRINOLYSIS
    10. Lundblad, RL; Kingdon, HS; Mann, KG; White, GC
      Issues with the assay of factor VIII activity in plasma and factor VIII concentrates

      THROMBOSIS AND HAEMOSTASIS
    11. Mann, KG
      How much factor v is enough?

      THROMBOSIS AND HAEMOSTASIS
    12. Eipers, PG; Kale, S; Taichman, RS; Pipia, GG; Swords, NA; Mann, KG; Long, MW
      Bone marrow accessory cells regulate human bone precursor cell development

      EXPERIMENTAL HEMATOLOGY
    13. van't Veer, C; Mann, KG
      The regulation of the factor VII-dependent coagulation pathway: Rationale for the effectiveness of recombinant factor VIIa in refractory bleeding disorders

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    14. Holmes, MB; Schneider, DJ; Hayes, MG; Sobel, BE; Mann, KG
      Novel, bedside, tissue factor-dependent clotting assay permits improved assessment of combination antithrombotic and antiplatelet therapy

      CIRCULATION
    15. van't Veer, C; Golden, NJ; Mann, KG
      Inhibition of thrombin generation by the zymogen factor VII: implications for the treatment of hemophilia A by factor VIIa

      BLOOD
    16. Pauls, JED; Hockin, MF; Long, GL; Mann, KG
      Self-association of human protein S

      BIOCHEMISTRY
    17. Bini, A; Mann, KG; Kudryk, BJ; Schoen, FJ
      Noncollagenous bone matrix proteins, calcification, and thrombosis in carotid artery atherosclerosis

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    18. Kalafatis, M; Bernardi, F; Simioni, P; Lunghi, B; Girolami, A; Mann, KG
      Phenotype and genotype expression in pseudohomozygous factor V-LEIDEN - The need for phenotype analysis

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    19. Long, MW; Ashcraft, EK; Normalle, D; Mann, KG
      Age-related phenotypic alterations in populations of purified human bone precursor cells

      JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
    20. Mann, KG
      Biochemistry and physiology of blood coagulation

      THROMBOSIS AND HAEMOSTASIS
    21. van't Veer, C; Butenas, S; Golden, NJ; Mann, KG
      Regulation of prothrombinase activity by protein S

      THROMBOSIS AND HAEMOSTASIS
    22. Mann, KG
      Blood coagulation

      ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
    23. Brummel, KE; Butenas, S; Mann, KG
      An integrated study of fibrinogen during blood coagulation

      JOURNAL OF BIOLOGICAL CHEMISTRY
    24. Butenas, S; van't Veer, C; Mann, KG
      "Normal" thrombin generation

      BLOOD
    25. Hockin, MF; Cawthern, KM; Kalafatis, M; Mann, KG
      A model describing the inactivation of factor Va by APC: Bond cleavage, fragment dissociation, and product inhibition

      BIOCHEMISTRY
    26. MOYER MP; TRACY RP; TRACY PB; VANTVEER C; SPARKS CE; MANN KG
      PLASMA-LIPOPROTEINS SUPPORT PROTHROMBINASE AND OTHER PROCOAGULANT ENZYMATIC COMPLEXES

      Arteriosclerosis, thrombosis, and vascular biology
    27. SMILES AM; MACY EM; SAKKINEN PA; BOVILL EG; MANN KG; TRACY RP
      VARIABILITY IN PLASMA PROTHROMBIN CONCENTRATION - IMPLICATIONS FOR USE IN EPIDEMIOLOGY

      Blood coagulation & fibrinolysis
    28. MANN KG; VANTVEER C; CAWTHERN K; BUTENAS S
      THE ROLE OF THE TISSUE FACTOR PATHWAY IN INITIATION OF COAGULATION

      Blood coagulation & fibrinolysis
    29. CALLAS PW; TRACY RP; BOVILL EG; CANNON C; THOMPSON B; MANN KG
      THE ASSOCIATION OF ANTICOAGULANT PROTEIN CONCENTRATIONS WITH ACUTE MYOCARDIAL-INFARCTION IN THE THROMBOLYSIS IN MYOCARDIAL-INFARCTION PHASE-II (TIMI-II) TRIAL

      Journal of thrombosis and thrombolysis
    30. LUNDBLAD RL; BERGSTROM J; DEVREKER R; BRAY G; GOMPERTS E; BAKER D; KINGDON HS; MANN KG; HARTSHORN J; JENNY RJ
      MEASUREMENT OF ACTIVE COAGULATION-FACTORS IN AUTOPLEX(R)-T WITH COLORIMETRIC ACTIVE SITE-SPECIFIC ASSAY TECHNOLOGY

      Thrombosis and haemostasis
    31. CASTOLDI E; KALAFATIS M; LUNGHI B; SIMIONI P; IOANNOU PA; PETIO M; GIROLAMI A; MANN KG; BERNARDI F
      MOLECULAR-BASES OF PSEUDO-HOMOZYGOUS APC RESISTANCE - THE COMPOUND HETEROZYGOSITY FOR FV R506Q AND A FV NULL MUTATION RESULTS IN THE EXCLUSIVE PRESENCE OF FV LEIDEN MOLECULES IN PLASMA

      Thrombosis and haemostasis
    32. MANN KG; VANTVEER C; CAWTHERN K; BUTENAS S
      THE EXPRESSION AND REGULATION OF PROTHROMBINASE

      British Journal of Haematology
    33. CAWTHERN KM; VANTVEER C; LOCK JB; DILORENZO ME; BRANDA RF; MANN KG
      BLOOD-COAGULATION IN HEMOPHILIA-A AND HEMOPHILIA-C

      Blood
    34. BOVILL EG; MANN KG; PHILLIPS D; VLASUK G; BECKER RC
      COLLEGE-OF-AMERICAN-PATHOLOGISTS CONFERENCE XXXI ON LABORATORY MONITORING OF ANTICOAGULANT-THERAPY - FUTURE-DIRECTIONS

      Archives of pathology and laboratory medicine
    35. MANN KG
      THROMBOSIS - DIAGNOSIS AND PROPHYLAXIS 1997

      Archives of pathology and laboratory medicine
    36. TRACY RP; KLEIMAN NS; THOMPSON B; CANNON CP; BOVILL EG; BROWN RG; COLLEN D; MAHAN E; MANN KG; ROGERS WJ; SOPKO G; STUMP DC; WILLIAMS DO; ZARET BL
      RELATION OF COAGULATION PARAMETERS TO POTENCY AND RECURRENT ISCHEMIA IN THE THROMBOLYSIS IN MYOCARDIAL-INFARCTION (TIMI) PHASE-II TRIAL

      The American heart journal
    37. KALAFATIS M; MANN KG
      FACTOR-V-LEIDEN AND THROMBOPHILIA

      Arteriosclerosis, thrombosis, and vascular biology
    38. HOCKIN MF; KALAFATIS M; SHATOS M; MANN KG
      PROTEIN-C ACTIVATION AND FACTOR VA INACTIVATION ON HUMAN UMBILICAL VEIN ENDOTHELIAL-CELLS

      Arteriosclerosis, thrombosis, and vascular biology
    39. EGAN JO; KALAFATIS M; MANN KG
      THE EFFECT OF ARG(306) -] ALA AND ARG(506) -] GLN SUBSTITUTIONS IN THE INACTIVATION OF RECOMBINANT HUMAN FACTOR VA BY ACTIVATED PROTEIN-C AND PROTEIN-S

      Protein science
    40. TRACY RP; RUBIN DZ; MANN KG; BOVILL EG; RAND M; GEFFKEN D; TRACY PB
      THROMBOLYTIC THERAPY AND PROTEOLYSIS OF FACTOR-V

      Journal of the American College of Cardiology
    41. BUTENAS S; DILORENZO ME; MANN KG
      ULTRASENSITIVE FLUOROGENIC SUBSTRATES FOR SERINE PROTEASES

      Thrombosis and haemostasis
    42. VANTVEER C; GOLDEN NJ; KALAFATIS M; SIMIONI P; BERTINA RM; MANN KG
      HEMOPHILIA-A AND FACTOR-V-LEIDEN

      Thrombosis and haemostasis
    43. VANTVEER C; GOLDEN NJ; MANN KG
      REGULATION OF PROTHROMBINASE ACTIVITY BY PROTEIN-S

      Thrombosis and haemostasis
    44. BUTENAS S; VANTVEER C; MANN KG
      EVALUATION OF THE INITIATION PHASE OF BLOOD-COAGULATION USING ULTRASENSITIVE ASSAYS FOR SERINE PROTEASES

      Thrombosis and haemostasis
    45. MANN KG; GOLDEN NJ; VANTVEER C
      TISSUE FACTOR PATHWAY TO THROMBIN - ANALYSES OF NORMAL CONCENTRATION VARIATIONS IN PROCOAGULANT AND ANTICOAGULANT FACTORS

      Thrombosis and haemostasis
    46. TORMENE D; KALAFATIS M; SIMIONI P; LUNGHI B; MANN KG; GIROLAMI A; BERNARDI F
      FACTOR-V AND FACTOR-V MESSENGER-RNA IN PSEUDO-HOMOZYGOUS ACTIVATED PROTEIN-C (APC) RESISTANCE

      Thrombosis and haemostasis
    47. HOCKIN MF; KALAFATIS M; MANN KG
      THE INACTIVE FORMS OF FACTOR VA

      Thrombosis and haemostasis
    48. KALAFATIS M; HOCKIN MF; MANN KG
      THE ACTIVE FORMS OF FACTOR VA

      Thrombosis and haemostasis
    49. KALAFATIS M; MANN KG
      PROTEOLYTIC ALTERATIONS OF MEMBRANE-BOUND FACTOR VA DURING INACTIVATION BY PLASMIN

      Thrombosis and haemostasis
    50. VANTVEER C; MANN KG
      REGULATION OF TISSUE FACTOR INITIATED THROMBIN GENERATION BY THE STOICHIOMETRIC INHIBITORS TISSUE FACTOR PATHWAY INHIBITOR, ANTITHROMBIN-III, AND HEPARIN COFACTOR-II

      The Journal of biological chemistry
    51. BUTENAS S; VANTVEER C; MANN KG
      EVALUATION OF THE INITIATION PHASE OF BLOOD-COAGULATION USING ULTRASENSITIVE ASSAYS FOR SERINE PROTEASES

      The Journal of biological chemistry
    52. MANN KG; HOCKIN MF; BEAN KJ; KALAFATIS M
      ACTIVATED PROTEIN-C CLEAVAGE OF FACTOR VA LEADS TO DISSOCIATION OF THE A2 DOMAIN

      The Journal of biological chemistry
    53. VANTVEER C; KALAFATIS M; BERTINA RM; SIMIONI P; MANN KG
      INCREASED TISSUE FACTOR-INITIATED PROTHROMBIN ACTIVATION AS A RESULT OF THE ARG(506)-]GLN MUTATION IN FACTOR-V-LEIDEN

      The Journal of biological chemistry
    54. VANTVEER C; GOLDEN NJ; KALAFATIS M; MANN KG
      INHIBITORY MECHANISM OF THE PROTEIN-C PATHWAY ON TISSUE FACTOR-INDUCED THROMBIN GENERATION - SYNERGISTIC EFFECT IN COMBINATION WITH TISSUE FACTOR PATHWAY INHIBITOR

      The Journal of biological chemistry
    55. SCHNEIDER DJ; TRACY PB; MANN KG; SOBEL BE
      DIFFERENTIAL-EFFECTS OF ANTICOAGULANTS ON THE ACTIVATION OF PLATELETSEX-VIVO

      Circulation
    56. TRACY RP; PSATY BM; TANG ZH; LEMAITRE RN; KULLER LH; MANN KG; SHARRETT AR; YANDELL DW
      COAGULATION-FACTOR-V GENETIC POLYMORPHISMS ASSOCIATED WITH CARDIOVASCULAR-DISEASE IN THE ELDERLY

      Circulation
    57. VANTVEER C; GOLDEN NJ; KALAFATIS M; SIMIONI P; BERTINA RM; MANN KG
      AN IN-VITRO ANALYSIS OF THE COMBINATION OF HEMOPHILIA-A AND FACTOR-V-LEIDEN

      Blood
    58. VANTVEER C; DILORENZO M; LOCK JB; MANN KG
      EFFECT OF PLATELET INHIBITORS ON THROMBIN GENERATION

      Blood
    59. EGAN JO; KALAFATIS M; SIMIONI P; MANN KG
      DISSOCIATION OF HUMAN FACTOR VA DOMAIN FRAGMENTS FOLLOWING ACTIVATED PROTEIN-C (APC) CLEAVAGE

      Blood
    60. HOCKIN MF; KALAFATIS M; CAWTHERN KM; MANN KG
      AN ANALYTICAL MODEL FOR THE ACTIVATED PROTEIN-C INACTIVATION OF FACTOR VA

      Blood
    61. EIPERS PG; BALLINGER C; MANN KG; LONG MW
      ISOLATION AND CHARACTERIZATION OF HUMAN BONE-MARROW MICROENVIRONMENTAL CELLS THAT REGULATE BONE PRECURSOR CELL-PROLIFERATION

      Blood
    62. BUTENAS S; KALAFATIS M; MANN KG
      ANALYSIS OF TISSUE-PLASMINOGEN ACTIVATOR SPECIFICITY USING PEPTIDYL FLUOROGENIC SUBSTRATES

      Biochemistry
    63. FANBURG JC; ROSENBERG AE; WEAVER DL; LESLIE KO; MANN KG; TAATJES DJ; TRACY RP
      OSTEOCALCIN AND OSTEONECTIN IMMUNOREACTIVITY IN THE DIAGNOSIS OF OSTEOSARCOMA

      American journal of clinical pathology
    64. MANN KG
      THROMBOSIS - THEORETICAL CONSIDERATIONS

      The American journal of clinical nutrition
    65. CARR JM; BOVILL EG; TRACY RP; MANKOWSKI M; MANN KG; MCDONAGH J
      CHANGES IN FIBRINOGEN AFTER RT-PA ADMINISTRATION

      Clinical and applied thrombosis/hemostasis
    66. JENNY NS; SHATOS MA; MANN KG
      MATRIX-SUPPORTED PROTEOLYSIS IN TISSUE-REPAIR

      The FASEB journal
    67. JENNY RJ; HARTSHORN J; MANN KG; LUNDBLAD RL
      QUANTITATION OF SERINE PROTEASES IN COMPLEX PROTEIN MIXTURES

      The FASEB journal
    68. EGAN JO; KALAFATIS M; MANN KG
      ACTIVATED PROTEIN C-MEDIATED INACTIVATION OF RECOMBINANT HUMAN FACTORVA

      Circulation
    69. VANTVEER C; GOLDEN NJ; MANN KG
      PARADOXICAL INHIBITION OF THROMBIN GENERATION BY THE ZYMOGEN FACTOR-VII

      Circulation
    70. RAND MD; LOCK JB; VANTVEER C; GAFFNEY DP; MANN KG
      BLOOD-CLOTTING IN MINIMALLY ALTERED WHOLE-BLOOD

      Blood
    71. CAWTHERN KM; VANTVEER C; LOCK JB; BRANDA FR; MANN KG
      REGULATION OF THROMBIN GENERATION BY TISSUE FACTOR, FACTOR VIIIA AND FACTOR XIA IN A WHOLE-BLOOD MODEL

      Blood
    72. EIPERS PG; BALLINGER C; TAICHMAN RS; MANN KG; LONG MW
      HUMAN BONE-MARROW MICROENVIRONMENTAL CELLS MODULATE BONE PRECURSOR CELL-DEVELOPMENT

      Blood
    73. JANEWAY CM; RIVARD GE; TRACY PB; MANN KG
      FACTOR-V QUEBEC REVISITED

      Blood
    74. KALAFATIS M; HALEY PE; LU DS; BERTINA RM; LONG GL; MANN KG
      PROTEOLYTIC EVENTS THAT REGULATE FACTOR-V ACTIVITY IN WHOLE PLASMA FROM NORMAL AND ACTIVATED PROTEIN-C (APC)-RESISTANT INDIVIDUALS DURING CLOTTING - AN INSIGHT INTO THE APC-RESISTANCE ASSAY

      Blood
    75. LU DS; KALAFATIS M; MANN KG; LONG GL
      COMPARISON OF ACTIVATED PROTEIN-C PROTEIN S-MEDIATED INACTIVATION OF HUMAN FACTOR-VIII AND FACTOR-V

      Blood
    76. CUTSFORTH GA; KOPPAKA V; KRISHNASWAMY S; WU JR; MANN KG; LENTZ BR
      INSIGHTS INTO THE COMPLEX ASSOCIATION OF BOVINE FACTOR V-A WITH ACIDIC-LIPID-CONTAINING SYNTHETIC MEMBRANES

      Biophysical journal
    77. BUTENAS S; MANN KG
      KINETICS OF HUMAN FACTOR-VII ACTIVATION

      Biochemistry
    78. SHATOS MA; ORFEO T; DOHERTY JM; PENAR PL; COLLEN D; MANN KG
      ALPHA-THROMBIN STIMULATES UROKINASE PRODUCTION AND DNA-SYNTHESIS IN CULTURED HUMAN CEREBRAL MICROVASCULAR ENDOTHELIAL-CELLS

      Arteriosclerosis, thrombosis, and vascular biology
    79. BOVILL EG; TRACY RP; HAYES TE; JENNY RJ; BHUSHAN FH; MANN KG
      EVIDENCE THAT MEIZOTHROMBIN IS AN INTERMEDIATE PRODUCT IN THE CLOTTING OF WHOLE-BLOOD

      Arteriosclerosis, thrombosis, and vascular biology
    80. KALAFATIS M; LU DS; BERTINA RM; LONG GL; MANN KG
      BIOCHEMICAL PROTOTYPE FOR FAMILIAL THROMBOSIS - A STUDY COMBINING A FUNCTIONAL PROTEIN-C MUTATION AND FACTOR-V LEIDEN

      Arteriosclerosis, thrombosis, and vascular biology
    81. MANN KG; KALAFATIS M
      THE COAGULATION EXPLOSION

      Cerebrovascular diseases
    82. LONG MW; ASHCRAFT EK; MANN KG
      AGE-RELATED ALTERATIONS IN BONE PROTEIN EXPRESSION BY PURIFIED POPULATIONS OF HUMAN BONE PRECURSOR CELLS

      Journal of bone and mineral research
    83. RAND MD; HANSON SR; MANN KG
      TURNOVER OF BABOON FACTOR-V AND FACTOR-V - EVIDENCE FOR A STABLE MARKER OF THROMBOSIS

      Thrombosis and haemostasis
    84. CAMIRE RM; KALAFATIS M; CUSHMAN M; TRACY RP; MANN KG; TRACY PB
      ACTIVATED PROTEIN-C-CATALYZED INACTIVATION OF PLATELET FV VA DERIVED FROM NORMAL AND APC-RESISTANT INDIVIDUALS/

      Thrombosis and haemostasis
    85. KALAFATIS M; BERTINA RM; RAND MD; MANN KG
      CHARACTERIZATION OF FACTOR-V FROM APC-RESISTANT PATIENTS HOMOZYGOUS FOR THE ARG506-]GLN MUTATION

      Thrombosis and haemostasis
    86. LU DS; KALAFATIS M; MANN KG; LONG GL
      FACTOR-V IS THE PREFERRED SUBSTRATE FOR ACTIVATED PROTEIN-C

      Thrombosis and haemostasis
    87. KALAFATIS M; MANN KG
      FACTOR-V LEIDEN AND THROMBOPHILIA

      The New England journal of medicine
    88. LONG MW; ROBINSON JA; ASHCRAFT EA; MANN KG
      REGULATION OF HUMAN BONE-MARROW-DERIVED OSTEOPROGENITOR CELLS BY OSTEOGENIC GROWTH-FACTORS (VOL 95, PG 881, 1995)

      The Journal of clinical investigation
    89. LONG MW; ROBINSON JA; ASHCRAFT EA; MANN KG
      REGULATION OF HUMAN BONE-MARROW-DERIVED OSTEOPROGENITOR CELLS BY OSTEOGENIC GROWTH-FACTORS

      The Journal of clinical investigation
    90. KALAFATIS M; BERTINA RM; RAND MD; MANN KG
      CHARACTERIZATION OF THE MOLECULAR DEFECT IN FACTOR V-R506Q

      The Journal of biological chemistry
    91. CAMIRE RM; KALAFATIS M; CUSHMAN M; TRACY RP; MANN KG; TRACY PB
      THE MECHANISM OF INACTIVATION OF HUMAN PLATELET FACTOR VA FROM NORMALAND ACTIVATED PROTEIN C-RESISTANT INDIVIDUALS

      The Journal of biological chemistry
    92. JONES KC; MANN KG
      A MODEL FOR THE TISSUE FACTOR PATHWAY TO THROMBIN .2. A MATHEMATICAL SIMULATION (VOL 269, PG 23367, 1994)

      The Journal of biological chemistry
    93. KALAFATIS M; DESHUN L; BERTINA RM; LONG GL; MANN KG
      A BIOCHEMICAL-MECHANISM FOR FAMILIAL THROMBOSIS

      Circulation
    94. RAND MD; HANSON SR; MANN KG
      FACTOR-V TURNOVER IN A PRIMATE MODEL

      Blood
    95. MURRAY JM; RAND MD; EGAN JO; MURPHY S; KIM HC; MANN KG
      FACTOR V-NEW (BRUNSWICK) - ALA(221)-TO-VAL SUBSTITUTION RESULTS IN REDUCED COFACTOR ACTIVITY

      Blood
    96. KALAFATIS M; HENDERSON SC; CAMIRE RM; HASSAN MI; MANN KG
      CLEAVAGE AT ARG(1545) ON HUMAN FACTOR-V IS NECESSARY FOR OPTIMUM FACTOR XA BINDING IN PROTHROMBINASE

      Blood
    97. JENNY NS; MANN KG
      INTERACTIONS OF FACTOR VA AND FACTOR VIIIA WITH ADHERENT PLATELETS AND PHOSPHOLIPID-BILAYERS

      Blood
    98. RAND MD; VANTVEER C; GAFFNEY DP; LOCK JB; MANN KG
      A MODEL FOR THE TISSUE FACTOR PATHWAY TO THROMBIN .3. THE EXTRINSIC CLOTTING PATHWAY INITIATED IN MINIMALLY ALTERED WHOLE-BLOOD

      Blood
    99. BUTENAS S; MANN KG
      KINETICS OF HUMAN FACTOR-VII ACTIVATION

      Blood
    100. KALAFATIS M; CAMIRE RM; SIMIONI P; GIROLAMI A; TRACY PB; MANN KG
      INCREASED RESISTANCE OF PLATELET-DERIVED FACTOR VA(R506Q) TO INACTIVATION BY ACTIVATED PROTEIN-C ON THE SURFACE OF ALPHA-THROMBIN ACTIVATEDPLATELETS

      Blood


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 02/06/20 alle ore 05:01:59